Pure Global AI
NCT05964166Enrolling by invitation

Tetragraph® Monitor: Tolerance of Preoperative Placement

Joseph D. TobiasClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Surgery
Drug/Device/Intervention
TetraGraph NMT Monitor
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Joseph D. Tobias
Funder
Nationwide Children's Hospital
Location
Columbus, United States of America
Timeline & enrollment
Phase
N/A
Start date
May 31, 2023
End date
Jun 01, 2024
Enrollment
100 participants
Primary outcome

Tolerance to preop placement as assessed by Likert scale

Summary

This is a prospective, non-blinded, single arm study. The primary objective of this study is
 to evaluate the tolerance to preoperative placement of the adhesive sensor for the
 Tetragraph® Neuromuscular Transmission Monitor in pediatric-sized patients ≤ 12 years of age.

ICD-10 classifications
Other surgical proceduresSurgical procedure, unspecifiedDuring surgical operationDuring surgical operationDuring surgical operation
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05964166
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05964166 through Pure Global AI's free database. This phase not specified trial is sponsored by Joseph D. Tobias and is currently Enrolling by invitation. The study focuses on Surgery. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.